Amgen falls 3% after 2019 outlook falls short
January 29, 2019 at 16:09 PM EST
The biotech company said it expects adjusted 2019 earnings per share between $13.10 and $14.30. That range is well below Wall Street projections for full-year earnings of $14.61 per share, according to a Refinitiv consensus estimate.
